移民工人进入马来西亚:考虑实施针对肠道寄生虫感染的大规模药物管理
Norhidayu Sahimin1,2, Nabila Abu Bakar, Yvonne Ai Lian Lim2
1Tropical Infectious Diseases Research and Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
International journal of health policy and management
|August 5, 2024
概括
马来西亚的移民工人没有充分的查寄生虫感染. 建议进行大规模除虫和改善卫生条件,以减少疾病传播和提高生产力.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
背景情况:
- 马来西亚的工业化和城市化导致低技能移民工人增加,主要来自东南亚和西亚.
- 目前对进入马来西亚的移民工人的医疗查不足以解决寄生虫感染的问题,尽管寄生虫感染在移民的祖国普遍存在.
- 寄生虫感染可能会影响移徙工人的福祉和生产力,并对公共卫生产生影响.
研究的目的:
- 突出目前对马来西亚移徙工人的寄生虫感染查不足.
- 倡导关于移民劳工健康管理的政策变化.
- 提出有效的策略来控制寄生虫感染在这个人群.
主要方法:
- 审查马来西亚移民工人目前的医疗查做法.
- 分析不足的寄生虫感染查对公共卫生的影响.
- 对控制肠道寄生虫感染 (IPI) 的潜在干预措施的评估.
主要成果:
- 肠道寄生虫感染 (IPI) 在马来西亚的移民工人中非常普遍.
- 现有的查方案不足以管理寄生虫感染的负担.
- 预防措施比治疗晚期感染更具成本效益.
结论:
- 马来西亚的国家卫生政策需要加强,包括对低技能移民工人的强制性大规模除虫.
- 持续的监测和改善的卫生条件对于控制寄生虫感染至关重要.
- 积极的健康干预措施,包括除虫运动和健康意识,对于长期的成本效益和工人福祉至关重要.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
113
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
113
Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156


